Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Molecular Cancer | journal | 8.703 Q1 | 196 | 208 | 475 | 17628 | 16683 | 427 | 28.64 | 84.75 | 40.29 | |
2 | Genome Medicine | journal | 4.851 Q1 | 123 | 141 | 381 | 10038 | 4632 | 370 | 11.63 | 71.19 | 43.95 | |
3 | EMBO Molecular Medicine | journal | 3.932 Q1 | 142 | 126 | 422 | 7785 | 4201 | 356 | 9.50 | 61.79 | 46.64 | |
4 | Journal for ImmunoTherapy of Cancer | journal | 3.403 Q1 | 117 | 531 | 1395 | 22237 | 14506 | 1384 | 9.00 | 41.88 | 42.18 | |
5 | Experimental and Molecular Medicine | journal | 3.380 Q1 | 115 | 188 | 502 | 13762 | 6193 | 486 | 12.62 | 73.20 | 38.53 | |
6 | Biomarker Research | journal | 2.379 Q1 | 48 | 89 | 189 | 8450 | 1797 | 173 | 9.63 | 94.94 | 41.37 | |
7 | Biomolecular Detection and Quantification | journal | 1.967 Q1 | 29 | 0 | 15 | 0 | 120 | 14 | 0.00 | 0.00 | 0.00 | |
8 | Molecular Therapy - Nucleic Acids | journal | 1.947 Q1 | 95 | 292 | 963 | 16402 | 8540 | 959 | 8.54 | 56.17 | 41.35 | |
9 | Human Genetics and Genomics Advances | journal | 1.920 Q1 | 13 | 75 | 35 | 4087 | 142 | 34 | 4.06 | 54.49 | 52.97 | |
10 | Molecular Therapy - Methods and Clinical Development | journal | 1.825 Q1 | 60 | 164 | 589 | 8119 | 3050 | 587 | 4.94 | 49.51 | 47.06 | |
11 | Molecular Oncology | journal | 1.778 Q1 | 113 | 232 | 601 | 15586 | 4099 | 586 | 6.79 | 67.18 | 46.18 | |
12 | Clinical and Translational Medicine | journal | 1.706 Q1 | 18 | 38 | 59 | 1817 | 279 | 25 | 4.81 | 47.82 | 39.48 | |
13 | Vaccine: X | journal | 1.509 Q1 | 18 | 110 | 95 | 4194 | 341 | 95 | 3.71 | 38.13 | 51.94 | |
14 | Stem Cell Research and Therapy | journal | 1.498 Q1 | 122 | 511 | 1471 | 33155 | 11612 | 1463 | 7.23 | 64.88 | 45.23 | |
15 | Cell Stress | journal | 1.434 Q1 | 27 | 12 | 93 | 451 | 494 | 93 | 5.38 | 37.58 | 51.02 | |
16 | Journal of Nanobiotechnology | journal | 1.421 Q1 | 109 | 527 | 729 | 41235 | 7105 | 729 | 9.67 | 78.24 | 40.75 | |
17 | Cellular oncology (Dordrecht) | journal | 1.408 Q1 | 58 | 82 | 229 | 6314 | 1399 | 226 | 6.27 | 77.00 | 44.43 | |
18 | Expert Review of Vaccines | journal | 1.346 Q1 | 105 | 178 | 333 | 13191 | 1886 | 316 | 6.10 | 74.11 | 44.05 | |
19 | Molecular Therapy - Oncolytics | journal | 1.339 Q1 | 42 | 154 | 420 | 9805 | 2379 | 420 | 5.60 | 63.67 | 40.14 | |
20 | Human Genomics | journal | 1.308 Q1 | 68 | 71 | 181 | 4582 | 933 | 173 | 4.26 | 64.54 | 43.70 | |
21 | Molecular Medicine | journal | 1.245 Q1 | 133 | 162 | 333 | 9799 | 1921 | 331 | 5.46 | 60.49 | 41.93 | |
22 | Journal of Cellular and Molecular Medicine | journal | 1.165 Q2 | 157 | 538 | 2900 | 24292 | 15896 | 2879 | 5.22 | 45.15 | 44.82 | |
23 | SLAS Discovery | journal | 1.042 Q2 | 33 | 56 | 318 | 1177 | 961 | 298 | 3.04 | 21.02 | 38.21 | |
24 | Molecular Biomedicine | journal | 1.023 Q2 | 16 | 48 | 59 | 7260 | 224 | 55 | 3.80 | 151.25 | 43.05 | |
25 | Frontiers in Genetics | journal | 1.000 Q2 | 120 | 3773 | 5783 | 205920 | 24113 | 5609 | 3.60 | 54.58 | 43.18 | |
26 | Cancer Biology and Therapy | journal | 0.996 Q2 | 130 | 64 | 356 | 2710 | 1604 | 354 | 3.28 | 42.34 | 38.20 | |
27 | Clinical Proteomics | journal | 0.941 Q2 | 42 | 48 | 111 | 2320 | 458 | 110 | 3.67 | 48.33 | 44.59 | |
28 | Biomarker Insights | journal | 0.878 Q2 | 40 | 32 | 51 | 2034 | 182 | 44 | 3.51 | 63.56 | 44.16 | |
29 | Drugs in Context | journal | 0.845 Q2 | 36 | 61 | 183 | 3786 | 735 | 183 | 2.96 | 62.07 | 55.06 | |
30 | Molecular Pain | journal | 0.824 Q2 | 96 | 55 | 239 | 2834 | 838 | 238 | 3.30 | 51.53 | 41.21 | |
31 | Journal of Pharmacological Sciences | journal | 0.801 Q2 | 101 | 108 | 346 | 4695 | 1254 | 346 | 3.55 | 43.47 | 30.14 | |
32 | Pharmaceuticals | journal | 0.799 Q2 | 87 | 1580 | 2000 | 114308 | 9707 | 1991 | 4.69 | 72.35 | 46.87 | |
33 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 31 | 138 | 1572 | 563 | 137 | 4.25 | 50.71 | 28.93 | |
34 | AIDS Research and Therapy | journal | 0.740 Q2 | 49 | 69 | 205 | 2803 | 520 | 205 | 2.25 | 40.62 | 49.85 | |
35 | FASEB BioAdvances | journal | 0.731 Q2 | 18 | 59 | 209 | 3156 | 593 | 201 | 2.86 | 53.49 | 42.07 | |
36 | EXCLI Journal | journal | 0.720 Q3 | 55 | 101 | 355 | 5713 | 1138 | 255 | 3.47 | 56.56 | 40.22 | |
37 | Molecules | journal | 0.704 Q3 | 227 | 9045 | 18462 | 568620 | 93896 | 18345 | 4.73 | 62.87 | 44.27 | |
38 | Molecular Imaging | journal | 0.697 Q3 | 66 | 21 | 56 | 902 | 188 | 56 | 2.59 | 42.95 | 40.40 | |
39 | Analytical Cellular Pathology | journal | 0.681 Q3 | 35 | 74 | 156 | 3033 | 557 | 153 | 3.04 | 40.99 | 41.54 | |
40 | Pharmaceutical Biology | journal | 0.646 Q3 | 88 | 216 | 409 | 9968 | 1818 | 408 | 3.98 | 46.15 | 43.81 | |
41 | Biomimetics | journal | 0.609 Q3 | 32 | 248 | 215 | 13944 | 1030 | 210 | 5.13 | 56.23 | 35.33 | |
42 | Pharmacogenomics and Personalized Medicine | journal | 0.469 Q3 | 37 | 82 | 255 | 3539 | 553 | 253 | 1.90 | 43.16 | 44.67 | |
43 | European Journal of Hybrid Imaging | journal | 0.453 Q3 | 14 | 37 | 71 | 976 | 161 | 68 | 2.32 | 26.38 | 30.90 | |
44 | Molecular Cytogenetics | journal | 0.443 Q3 | 38 | 52 | 162 | 1641 | 273 | 161 | 1.32 | 31.56 | 57.93 | |
45 | Molecular and Cellular Oncology | journal | 0.436 Q3 | 37 | 17 | 312 | 392 | 347 | 220 | 1.05 | 23.06 | 54.55 | |
46 | Open Medicinal Chemistry Journal | journal | 0.352 Q4 | 23 | 6 | 22 | 464 | 50 | 19 | 2.75 | 77.33 | 46.67 | |
47 | Biointerface Research in Applied Chemistry | journal | 0.336 Q4 | 30 | 556 | 1028 | 30346 | 2677 | 1025 | 2.74 | 54.58 | 42.51 | |
48 | Turkish Journal of Pharmaceutical Sciences | journal | 0.303 Q4 | 22 | 89 | 267 | 3368 | 486 | 257 | 1.78 | 37.84 | 48.89 | |
49 | Nanomedicine Research Journal | journal | 0.255 Q4 | 20 | 40 | 112 | 2035 | 179 | 112 | 1.49 | 50.88 | 49.35 | |
50 | Eurobiotech Journal | journal | 0.230 Q4 | 10 | 17 | 71 | 1286 | 143 | 70 | 1.96 | 75.65 | 38.46 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®